Latest news
Loading news…
Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
Constellation Pharmaceuticals was acquired by MorphoSys in 2021 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
27
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cambridge, Massachusetts, United States
Key People at Constellation Pharmaceuticals
Founder
27
professional contacts at Constellation Pharmaceuticals
Contact execs at Constellation Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Constellation Pharmaceuticals
Loading news…
FAQs about Constellation Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.